Further, hormone receptors are weak predictors of patient outcome [26]–[28], [30]; only the combined absence of ERα, PgR and HER-2/neu associates with aggressive triple-negative breast cancers [31]. The gene discussed is PGR; the disease is triple-negative breast carcinoma.